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Introduction
Insulin therapy is required in patients with severe insulin deficiency, which is observed frequently in insulindependent diabetes mellitus (IDDM) and sometimes in non-insulin-dependent diabetes mellitus (NIDDM). For insulin therapy, three types of insulin preparations are currently used: rapid-acting, intermediate-acting (lente), and long-acting (ultralente). 1 The three types differ in the mode of action, as shown by their name, and are therefore used in combination in clinical practice. Although insulin therapy for diabetes mellitus is well-established, an ideal goal would be to confer insulin-producing capacity to other cells, similar to production by pancreatic ␤ cells in insulin-deficient patients.
For engineering insulin-producing capacity, two types of cells are available: neuroendocrine and non-neuroendocrine. Upon extracellular stimulation, neuroendocrine cells exocytose secretory granules containing a mature bioactive peptide hormone that is converted from its precursor propeptide. This cell type may correspond to the mode of action of rapid-acting insulin. Newgard's group [2] [3] [4] [5] used mouse pituitary corticotroph-derived AtT20 cells for expressing insulin. Since AtT20 expressed glucose-sensing glucokinase endogenously, Newgard's group introduced glucose transporter type 2 (Glut2)
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Received 27 October 1997; accepted 10 February 1998 DNA into the cells, together with human insulin DNA. The cells thus engineered secreted insulin in response to a physiological range of glucose concentrations. Recently, a similar device was given to a rat insulinoma cell line, RIN1046-38. New sublines engineered with multiple copies of human insulin, glucokinase and Glut2 genes contained a high level of insulin, comparable to that in human islets, and secreted insulin in a glucose-regulated fashion. 6, 7 These cell lines, however, are of tumor origin and increase in cell number autonomously. Thus, neuroendocrine cells of nontumor origin are desirable as target cells for gene transfer. Lipes et al 8 expressed insulin as a transgene in pro-opiomelanocortin-producing pituitary intermediate lobe, then transplanted this tissue into nonobese diabetic mice. These mice registered near normal blood glucose levels. Unless such a transgene-introduced model is used, however, neuroendocrine tissues are difficult to collect and perform efficient gene transfer.
On the other hand, non-neuroendocrine cells, such as hepatocytes or muscle cells, are easily obtained, but unlike neuroendocrine cells, must be engineered with a processing mechanism and a regulatory secretion system. For engineering a processing mechanism, we utilized a ubiquitously distributed yeast Kex2 family endoprotease furin. [9] [10] [11] A similar device for the human insulin gene was made by other groups. [12] [13] [14] Proinsulin is processed to mature insulin by two proteolytic reactions in pancreatic ␤ cells: first, by the prohormone convertases PC2 and PC3 (also named PC1); and second, by carboxypeptidase H. Although these two reactions appeared to be specific to neuroendocrine cells, by first mutating proinsulin to contain furin-cleavable processing sites, we were able to produce correctly processed insulin from the insulin gene-introduced non-neuroendocrine cell lines including COS-7, HepG2, CHO and NIH3T3. [9] [10] [11] For regulating insulin production from non-neuroendocrine cells, we utilized a phosphoenolpyruvate carboxykinase (PEPCK) promoter. 15 Because these cells do not carry secretory granules but secrete proteins and peptides through a constitutive pathway without being retained in the cytoplasm, the regulation of insulin production is limited to the gene transcription level. Production of a bioactive peptide from its gene activation requires more time than does exocytosis in neuroendocrine cells. Thus, insulin production from non-neuroendocrine cells may correlate more closely to intermediateacting or long-acting insulin. The most desirable regulator of insulin production, even at the transcription level, is glucose, which regulates the expression of many genes in pancreatic ␤ cells and hepatocytes, [16] [17] [18] both of which possess Glut2 and glucokinase for responding to a physiological range of glucose concentrations. 2, 5 Initially, we attempted to use glucose-responsive promoters for the rat S-14 mRNA gene and rat L-type pyruvate kinase, 19 ,20 but we were unsuccessful in using these promoters to regulate insulin production from rat hepatocytes because the glucose activation of these promoters was weak. Thus, we used a PEPCK promoter that is known to be up-regulated by cAMP, glucocorticoids and retinoic acid, and down-regulated by insulin and phorbol ester. [21] [22] [23] [24] PEPCK, highly expressed in hepatocytes, catalyzes oxaloacetate to phosphoenolpyruvate by taking phosphate from GTP. This enzyme acts as a key step in hepatic glucose production. 16 In severe diabetic subjects, production of this enzyme is highly increased by insulin deficiency. We previously examined insulin production by expressing a PEPCK promoter plus insulin DNA construct in the rat hepatoma cell line H4IIE. 15 H4IIE cells secreted immunoreactive insulin (IRI), which we increased five-fold using cAMP and the cAMP-dependent phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX), and 18-fold by the further addition of dexamethasone. The addition of exogenous insulin to the culture medium significantly decreased insulin mRNA expression in H4IIE cells.
Because a H4IIE cell line is of tumor origin and grows autonomously, we attempted to use nontransformed cells for the regulatable insulin production. We thought that primary cultured hepatocytes would be the cells of choice as the target cells for gene transfer. The liver has been used as an anchoring place for pancreatic islet transplantation. 25 Although Weir and Bonner-Weir 26 reported the poor success of islet transplantation that had been performed intrahepatically through the portal vein in 270 IDDM patients until 1995, there have been several successful cases that became insulin independent. Recently, Carroll et al 27 reported an over 3-year insulin dependence in a patient with intrahepatic islet transplantation. Moreover, pulsatile insulin secretion was demonstrated by chronically transplanted intrahepatic islets in dogs. 28 Hepatocytes are relatively inefficient for DNA transfer using conventional gene transfer methods. 29 To transfer the PEPCK promoter plus insulin DNA expression unit to liver cells, several vectors can be taken into account including retrovirus, liposome and adenovirus. Retroviral vectors have been improved by raising their relatively weak titers, but their DNA transfer has to depend on ex vivo infection to hepatocytes. 30 Furthermore, retroviral expression requires cell division for its chromosomal integration. Partial hepatectomy is often carried out to induce cell division in the liver, 31 however, hepatectomy is not a practical procedure for clinical use. Liposome is also used for gene transfer to liver cells, 32 but the liposomal DNA transfer is not efficient and also requires cell division for DNA integration into chromosomes. In contrast, adenoviral gene transfer to liver cells is extremely efficient and does not require cell division since adenoviral DNA replication and transcription is extrachromosomal. 33 The drawback of this adenoviral vector is its immunogenicity, so that repetitive adenoviral DNA transfer to animals results in the elimination of its gene products. However, Tripathy et al 34 reported that the expression of endogenous proteins in animals lessens the development of their immunorejection. Kay et al 35 demonstrated, furthermore, the effect of CTLA4Ig, a costimulatory signal inhibitor between T lymphocytes and antigen-presenting cells. With the use of CTLA4Ig, persistent adenoviral gene expression was obtained in mice without long-term immunosuppression. Thus, we decided to construct a regulatable insulin expression system by using an adenoviral vector. 36, 37 Using a recombinant adenoviral vector, we observed the production of mature insulin by primary cultured rat hepatocytes and found that insulin secretion from hepatocytes is up-regulated by glucagon and dibutyryl cAMP (dbcAMP) and down-regulated by insulin itself. Insulin production was augmented by the presence of wortmannin, thought to block the insulin receptor-mediated signaling pathway, possibly by inhibiting phosphatidylinositol (PI)-3-kinase. 38 
Results
Construction of a regulatable insulin expression system using an adenovirus vector To make a regulatable insulin expression system, we first inserted an insulin expression unit to the SwaI site of a cassette cosmid pAdex1cw, then transfected human embryonal kidney-derived 293 cells with Ad5-dlX DNA carrying terminal proteins at both ends. 36 The presence of terminal protein protects the Ad5-dlX DNA from exonuclease attack, therefore a homologous recombination between the pAdex1cw and Ad5-dlX becomes far more efficient in 293 cells. After selecting recombinant adenoviruses with an insulin expression vector, AdP 3 ␤Ins and AdP 0 ␤Ins ( Figure 1 ) were propagated for use in insulin gene transfer to hepatocytes.
Optimal conditions for IRI production
For adenoviral DNA transfer, hepatocytes were cultured to almost confluency (6-7 × 10 4 /cm 2 ). Using this hepatocyte culture, we examined IRI production by three multiplicities of infection (MOI) of 2, 10 and 50. By 2 and 10 MOI of AdP 3 ␤Ins or AdP 0 ␤Ins, IRI production continued to increase up to 72 h after infection ( Figure 2 , closed circles). By a 50 MOI, IRI was highly produced, but the production plateaued after 48 h. To examine the effect of dbcAMP and IBMX, we used the optimal amounts previously reported for the H4IIE, which were 300 m dbcAMP and 500 m IBMX. 15 The addition of these doses to the culture medium enhanced IRI production at all time-points for hepatocytes infected with all three MOI numbers of AdP 3 ␤Ins (Figure 2a) . By 2 and 50 MOI, the slope of increase became steeper after 24 h. By 50 MOI, the increase became smaller toward 72 h. In contrast, the increase was not observed in hepatocytes infected with any MOI of AdP 0 ␤Ins (Figure 2b ). This suggests that the regulatable effect of PEPCK promoter on IRI production is evident in hepatocytes. From the relative increase of IRI in the presence over the absence of cAMP, we noted that regulatable insulin production is diminished with higher insulin levels, especially over 10-20 pmol/10 6 cells (5-10 ng/ml). This finding indicates that regulation by PEPCK promoter is effective below 5-10 ng/ml of insulin levels which cover a normal range of plasma IRI (0.2-3 ng/ml). Because the relative increased ratio of IRI production with versus without stimulants was most remarkable at 9 h after adenovirus infection (over four-fold) (Figure 2c ), we evaluated IRI production from hepatocytes 9 h after infection.
To determine an optimal M.O.I, 37 100 l of recombinant adenovirus AdP 3 ␤Ins stock with a MOI of 10, 50, 200 and 1000 was added to the culture of hepatocytes, then incubated for 1 h. After infection, hepatocytes were cultured with a new medium for an additional 9 h, then the medium was harvested for IRI measurement. IRI production gradually increased to a 1000 MOI, although the slope was steepest between 0 and 200 MOI (Figure 3a) . IRI production increased with dbcAMP and IBMX in the culture medium as observed in Figure 2 . By comparing the ratio of IRI with the nonstimulant control, we found that the increase was most remarkable at a 50 MOI (a little less than five-fold) (Figure 3b) . We then evaluated a 50 MOI at half and at twice the hepatocyte cell density, and found that the original cell density of 6-7 × 10 4 /cm 2 was best for IRI production (data not shown). Furthermore, we examined glycogen storage in hepatocytes infected by 0, 50 and 200 MOI of the adenovirus vectors. After infection, hepatocytes were cultured for 48 h for glycogen staining. High levels of insulin by a 200 MOI (IRI, over 10 pmol/ml) did not cause overstorage of glycogen in hepatocytes (Figure 3c ). Thus, we thought that 9-h hepatocyte culture after the 50 MOI infection was optimal for observing insulin production.
Regulatable production of IRI
We examined the regulatable production of IRI after the infection with AdP 3 ␤Ins by increasing the dosage of c b a cAMP and glucagon. IRI production increased up to 100 m dbcAMP, then reached a plateau up to 500 m (Figure 4a ). The increase of IRI was approximately fourfold. IRI production was also increased by glucagon (Figure 4b ). The increase was observed up to 100 pm glucagon, then IRI production plateaued up to 10 nm. The increase by glucagon was also close to four-fold. Thus, the marked IRI increase was obtained by a natural stimulant, glucagon.
Suppressive effect of insulin on insulin expression
We examined the inhibitory effect of insulin on IRI production indirectly by two methods. First, we evaluated the IRI production with and without the addition of wortmannin, a PI 3-kinase inhibitor. Wortmannin reportedly blocks the insulin receptor-mediated signaling pathway to the PEPCK promoter by inhibiting PI-3-kinase. 38 Thus, we were able to eliminate the inhibitory effect of endogenous insulin on IRI production. The enhancing effect of wortmannin on IRI production was remarkable when the hepatocytes were infected with the PEPCK promoter-containing AdP 3 ␤Ins (Figure 5a ). This enhancement was observed both in the presence and absence of 1.0 nm glucagon + 500 m IBMX. Wortmannin had no effect, however, on IRI production in hepatocytes infected with the PEPCK promoterless AdP 0 ␤Ins ( Figure  5b ). The wortmannin effect was also noted when cAMP + IBMX was added to the hepatocyte culture (data not shown).
The second method for investigating the inhibitory effect of insulin was to measure insulin mRNA expression in hepatocytes after increasing exogenous insulin from 0, 0.1 and 1.0 to 10 nm in the medium. The expression of insulin mRNA was observed both in the absence (Figure 6a ) and presence of 1.0 nm glucagon + 500 m IBMX (Figure 6b ). Insulin expression decreased as exogenous insulin dosage increased, with or without stimulants. It should be noted, however, that the inhibitory effect of exogenous insulin was more pronounced in the absence than in the presence of stimulants. The inhibitory effect was also observed when cAMP + IBMX was added simultaneously with insulin (data not shown). 
Figure 4 Regulatable production of IRI with cAMP and glucagon. Stimulants were added to the culture medium at infection. IRI in the medium was assayed 9 h after the infection with AdP

Figure 6 (a) and (b) Northern blot analysis of insulin mRNA. Exogenous insulin was added to the culture infected with AdP 3 ␤Ins at a final concentration of 0, 0.1. 1.0 and 10 nm (indicated at top). Cells were cultured without (a) or with (b) 1.0 nm glucagon + 500 m IBMX. In upper panels, an arrowhead indicates 18S ribosomal RNA. In lower panels, arrowheads show 28S and 18S ribosomal RNAs, stained with ethidium bromide, respectively (a and b).
Thus, overdose of exogenous insulin is effective in suppressing the expression of insulin mRNA.
Production of mature insulin and its biological activity
The insulin DNA we used in this study was mutated to express proinsulin with furin-cleavable sites, which can be converted to mature insulin in non-endocrine cells such as hepatocytes. 9, 10, 15 As expected, the hepatocytes infected with the adenoviral insulin expression vector produced mature insulin as a major fraction and proinsulin as a minor fraction (Figure 7a ). Since we did not make an adenoviral insulin expression vector carrying native insulin gene, we could not compare the processing between native and mutated proinsulin in hepatocytes. But the expression of the mutated proinsulin at least rendered hepatocytes to be the production of mature insulin. Utilizing this insulin fraction we examined its biological activity by measuring the uptake of 3-O-[ 3 H]methyl-d-glucose into adipocytes isolated from a rat
Figure 7 Production of biologically active insulin. (a) Reverse phase HPLC separation of insulin from the engineered hepatocytes. The culture medium was applied to a Vydak C18 column. I, standard human insulin. PI, standard human proinsulin. Similar elution profiles were obtained by at least three other HPLC separations. (b) Uptake of 3-O-methylglucose to adipocytes stimulated by the mature insulin obtained from the HPLC (a) (í), standard human insulin; (), mature insulin obtained from the HPLC. Bars indicate standard deviation.
epididymal adipose tissue. Insulin from the engineered hepatocytes exhibited a similar glucose uptake activity to the standard human synthetic insulin at two different concentrations (25 and 100 pm) (Figure 7b) . Thus, the insulin molecules from hepatocytes are fully functional in terms of glucose uptake capability.
Discussion
A number of pancreatic islet transplantations have been performed through the portal vein, so that the liver is thought to be a suitable place for insulin production. [25] [26] [27] [28] By high levels of insulin, hepatocytes may accumulate a high amount of glycogen, but we did not observe overstorage of glycogen in hepatocytes infected with a high MOI number of the adenovirus vector. In insulin gene transfer studies targeted to hepatocytes so far, insulin secretion is constitutive, without any regulation. 32, 39 Acting as surrogate pancreatic ␤ cells, hepatocytes can secrete insulin in response to high glucose concentrations. Furthermore, because hepatocytes do not contain secretory granules, they secrete proteins such as albumin through a constitutive pathway. As such, a feasible maneuver for engineering a regulatable step for insulin secretion in hepatocytes appears to be limited to gene transcription; however, Simpson et al 40 recently reported that insulin secretion in a human hepatoma cell line, HepG2, is regulated by 8-bromo cAMP and IBMX. In their study the human insulin gene was introduced, under the control of a cytomegalovirus promoter, into HepG2, a cell line that contains large vacuoles that may contain expressed insulin molecules. Previously, we reported success with a rat insulin-expressing HepG2 cell line. 10 Although we stimulated these HepG2 cells with the same stimulants used by Simpson et al, we could not obtain any regulatable production of insulin from HepG2 cells. At present, we cannot explain the difference in the stimulant-induced responsiveness of HepG2 cells between these two studies. Alternatively, we used a PEPCK promoter for the regulatable production of insulin. Known to be enhanced by cAMP, glucocorticoids and retinoic acids, this promoter is suppressed by insulin and phorbor ester. [21] [22] [23] [24] Because phorbor esters exert a tumorpromoting action, and because glucocorticoids induce insulin resistance in peripheral tissues and decrease Glut2 expression in pancreatic ␤ cells, 41, 42 we did not use these stimulants in this study. To obtain basal insulin secretion, we examined two basal promoters for thymidine kinase and ␤ actin by placing each between the PEPCK promoter and insulin DNA. IRI production using the ␤ actin promotor was higher than that using the thymidine kinase promoter, so we used an insulin expression vector containing a ␤ actin promotor. We also used a mutant proinsulin DNA carrying furin-cleavable processing sites, 9-11 expression of which resulted in the production of biologically active mature insulin in hepatocytes ( Figure 7) . By using these insulin expression vectors, we were successful in achieving regulatable production of insulin from H4IIE cells, 15 however, we could not obtain enhanced production of insulin from the H4IIE using glucagon, which is known to increase the cAMP level in hepatocytes. In severe diabetes, a high level of plasma glucagon is invariably observed, and this level is decreased by insulin therapy, 43 therefore, regulation of insulin production by glucagon is preferable. In this study, glucagon was effective in enhancing the production of insulin from hepatocytes after infection with AdP 3 ␤Ins, unlike in the hepatoma cell lines H4IIE and HepG2 (Figure 4) .
Insulin suppresses PEPCK promoter activity, 21, 23 but the concentration-induced inhibition of insulin production in insulin-producing cells is difficult to observe. Thus, we assessed inhibition by two methods: Northern blot analysis and wortmannin treatment. On Northern blot, adding exogenous insulin to the culture decreased the expression of insulin message. But the inhibitory effect of insulin was weak, probably due to high activity of basal ␤ actin promoter. Furthermore, the inhibitory effect of insulin was demonstrated by the observation that IRI production by hepatocytes was increased twofold in the presence of wortmannin, with or without stimulant. Insulin signaling to the PEPCK promoter was mediated at least through PI-3-kinase after the autophosphorylated insulin receptor-insulin receptor substrate-1 interaction. 38 The fact that wortmannin increased the insulin production from hepatocytes indicates that PEPCK promoter activity is partially suppressed by insulin, its own promoting product.
By using the PEPCK promoter, we succeeded in achieving the regulatable production of insulin from primary cultured rat hepatocytes. Since plasma insulin levels fluctuated from 1 to 3 ng/ml, insulin production should effectively be suppressed by the plasma level of 5-10 ng/ml, or approximately 1-2 nm. Exogenous insulin as high as 10 nm, however, did not effectively suppress the expression of insulin mRNA, especially in the presence of the stimulants (Figure 6 ). Thus, we need to improve further the autonomously regulated range of insulin secretion by adjusting the activity of a basal promoter. Despite the need for further study, it appears that the adenoviral insulin expression system described here is applicable to in vivo study. We are currently in the process of examining this expression system using diabetic animals.
Materials and methods
Construction of a regulatable insulin expression system using an adenoviral vector We used a regulatable insulin expression vector that was previously constructed. 15 The vector comprises the following segments: three copies of PEPCK promoter (−598 approximately −31) as a regulatable promoter, a chicken ␤-actin promoter (−1274 approximately −1) as a basal promoter; a rat insulin gene I with furin-cleavable sites; and a rabbit ␤-globin 3Ј flanking sequence including a polyadenylation signal (P 3 ␤Ins). We deleted a PEPCK segment (P 0 ␤Ins) as a nonregulatable expression vector. We confirmed previously that more efficient control of insulin expression is obtained by using three copies of the PEPCK promoter than by using one or other multiple copies. 15 This insulin expression unit was cut from the plasmid and inserted into the SwaI site of the cassette cosmid pAdex1cw (pAdP 3 ␤Ins and pAdP 0 ␤Ins).
36
Recombinant virus was generated by a homologous recombination between either pAdP 3 ␤Ins or pAdP 0 ␤Ins and the EcoT22I-digested DNA-terminal protein complex of Ad5-d1X 36 in human embryonic kidney 293 cells (ATCC, CRL 1573). Because the 293 cells are integrated with the adenoviral E1A region, E1A-deleted adenoviral recombinant DNA can propagate in the cells. The day after the homologous recombination was performed, the 293 cells were spread to three 96-well culture plates, then cultured for 15 days. The culture medium was harvested as a virus stock from wells that contained lysed cells. Viral DNA was isolated for restriction analysis by XhoI, according to the method described previously. 36 After confirming the presence of the insulin expression unit, the recombinant virus was increased for purification by velocity density gradient centrifugation. 44 A virus titer was determined using the 293 cells, and the MOI was calculated for each infection experiment. 37 The structure of AdP 3 ␤Ins and AdP 0 ␤Ins is shown in Figure 1 .
Primary culture of hepatocytes and adenovirus infection
Six-week-old male Wistar rats (approximately 200 g each) were used for hepatocyte isolation. Hepatocytes were isolated according to a previously described method. 45, 46 Briefly, the liver was first perfused via the portal vein with Ca 2+ -free Krebs-Ringer bicarbonate buffer, followed by the same buffer containing 1.25 mmol/l Ca 2+ , 0.05% collagenase and 0.005% trypsin inhibitor. The liver was then removed, minced and dispersed, then collagenasetreated cells were filtered through nylon mesh. Isolated hepatocytes were plated on to collagen-coated dishes at a density of 6-7 × 10 4 cells/cm 2 in Williams' medium E supplemented with 10 nmol/l dexamethasone, 10 nmol/l insulin, 25 mmol/l glucose, 5% fetal calf serum, streptomycin and penicillin. Hepatocytes were allowed to attach for 3 h, then were cultured with fresh medium overnight.
Before virus infection, cells were washed with serum-free Williams' medium E containing 0.1% bovine serum albumin and 11 mmol/l glucose, then virus in a total volume of 100 l was added to each well for 1 h with an indicated MOI value.
Hepatocytes can be cultured maximally for 5-6 days after isolation, but their viability decreases with time. 46 Thus, we used hepatocyte culture of 4 days in this study; and so the longest observation of insulin production was 72 h.
Measurement of immunoreactive insulin
Immunoreactive insulin (IRI) in the culture medium was detected using a time-resolved immunofluorometric assay system. 47 Glycogen staining Glycogen stored in hepatocytes was stained with the Best's method 48 using the staining solution composed of carmine.
Regulation of insulin production
To observe the regulatable production of IRI, the following chemicals were added to the medium: human glucagon (Peptide Institute, Osaka, Japan), human insulin, the cAMP analog N 6 ,2,0-dibutyryl cAMP (dbcAMP), cAMPdependent phosphodiesterase inhibitor IBMX and wortmannin (Calbiochem, La Jolla, CA, USA). Human insulin, human proinsulin, dbcAMP and IBMX were purchased from Sigma (St Louis, MO, USA). The hepatocytes were incubated with each chemical for 9 h after 1 h infection with the adenoviral insulin expression vector. In the experiment of IRI production up to 72 h infection, the incubation of hepatocytes with each chemical continued to an indicated time from 3 to 72 h.
Northern blot
Total RNA was isolated from the hepatocytes using the TRIzol TM Reagent (Life Technologies, Gaithersburg, MD, USA). Total RNA was electrophoresed on a 1% agarose gel, and transferred to a nylon membrane (Amersham Life Science, Tokyo, Japan) using the capillary blotting technique. Hybridization was performed with a probe of the rat insulin gene-I DNA fragment (350 base pairs), labeled with ␣-32 P deoxy-CTP by the random priming procedure. The membrane was exposed to radiographic film (Eastman Kodak, Rochester, NY, USA) with an intensifying screen at −80°C. Autoradiograms were densitometrically scanned to quantify insulin RNA levels in the hepatocytes.
HPLC analysis
The medium from hepatocyte culture was centrifuged at 8000 g for 10 min to remove contaminating cells or cell debris, then a total 1.5 ml of medium was applied to a reverse phase HPLC analyzer (Waters 625 LC system; Millipore, Milford, MA, USA). HPLC analysis was carried out using a Vydak C18 column (4.5 × 250 mm; YMC Separation Technology, Tokyo, Japan). The column was equilibrated with 28% acetonitrile in 0.1% trifluoroacetic acid and eluted with a linear gradient of 28% to 40% acetonitrile in 0.1% trifluoroacetic acid. 49 Fractions of 1 ml each were collected and neutralized by 100 l of 0.5 m borate (pH 9.5) containing 0.5% (w/v) BSA for insulin RIA.
Measurement of glucose uptake
Glucose uptake activity of adipocytes stimulated by insulin was assayed by measuring the uptake rate of 3-Omethyl-d-glucose as described previously. 9 Adipocytes isolated from a rat epididymal tissue by collagenase digestion were incubated with 100 m 3-O-[ 3 H] methyld-glucose (86.7 Ci/mmol; NEN Life Science Products, Wilmington, DE, USA) in the presence or absence of insulin for 3 s at 37°C in a total volume of 100 l. The reaction was terminated by adding 300 l of 1 mm phloretin, a glucose transport inhibitor, and the measurement of radioactivity in the cell fraction was carried out as described previously. 9 
